Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorFinance
Phone860-226-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$48.65 billion
Profitability
Miscellaneous
Employees46,000
OptionableOptionable
Cigna (NYSE:CI) Frequently Asked Questions
What is Cigna's stock symbol?
Cigna trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."
How often does Cigna pay dividends? What is the dividend yield for Cigna?
Cigna announced a quarterly dividend on Wednesday, February 28th. Stockholders of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 annualized dividend and a dividend yield of 0.08%. The ex-dividend date is Friday, March 9th. View Cigna's Dividend History.
How will Cigna's stock buyback program work?
Cigna announced that its board has approved a stock buyback plan on Sunday, June 4th 2017, which permits the company to buyback $3,700,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 9.8% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's leadership believes its stock is undervalued.
How were Cigna's earnings last quarter?
Cigna Corp (NYSE:CI) posted its quarterly earnings data on Friday, February, 1st. The health services provider reported $2.46 EPS for the quarter, missing the Zacks' consensus estimate of $2.53 by $0.07. The health services provider had revenue of $13.75 billion for the quarter, compared to analysts' expectations of $11.38 billion. Cigna had a return on equity of 16.64% and a net margin of 5.42%. The company's revenue was up 29.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.94 EPS. View Cigna's Earnings History.
When is Cigna's next earnings date?
What guidance has Cigna issued on next quarter's earnings?
Cigna issued an update on its FY19 earnings guidance on Friday, February, 1st. The company provided EPS guidance of $16.00-16.50 for the period, compared to the Thomson Reuters consensus estimate of $17.14. The company issued revenue guidance of $131.5-133.5 billion, compared to the consensus revenue estimate of $135.58 billion.Cigna also updated its FY 2019 guidance to EPS.
What price target have analysts set for CI?
16 analysts have issued 12 month target prices for Cigna's stock. Their predictions range from $181.30 to $299.00. On average, they expect Cigna's share price to reach $230.4044 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price. View Analyst Price Targets for Cigna.
What is the consensus analysts' recommendation for Cigna?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cigna in the last year. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cigna.
What are Wall Street analysts saying about Cigna stock?
Here are some recent quotes from research analysts about Cigna stock:
- 1. According to Zacks Investment Research, "Shares of Cigna have outperformed its industry's growth in six months' time. The company has completed the acquisition of Express Scripts, which should lead to long-term growth. A robust Global Supplemental business, growing Government business, increasing membership, and strong capital position are the other positives. Strong 2018 outlook reflects business strength. However, increase in leverage, rise in operating expenses and suspension of share buyback might weigh on earnings." (1/4/2019)
- 2. Cantor Fitzgerald analysts commented, ". We initiate coverage of Overweight rating and a 12-month price target of $245. Cigna is a large-cap health insurance company with a focus on self-insured employers. Segment accounted for 80% of operating revenue and 77% of adjusted operating income. The company also operates supplemental benefits and group disability and life businesses. the company announced the acquisition of Express Scripts (ESRX – Not Covered), a large pharmacy benefit manager (PBM). We believe the transaction, which should close by year-end 2018, is a logical fit, both strategically and financially, with natural synergies." (9/26/2018)
Has Cigna been receiving favorable news coverage?
Media coverage about CI stock has trended somewhat positive on Sunday, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cigna earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news headlines about the health services provider a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
Who are some of Cigna's key competitors?
Who are Cigna's key executives?
Cigna's management team includes the folowing people:
- Mr. David Michael Cordani, Pres, CEO & Director (Age 54)
- Mr. Eric Paul Palmer, Exec. VP & CFO (Age 42)
- Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 48)
- Mr. Matthew Glenn Manders, Pres of Strategy & Solutions (Age 57)
- Mr. Jason D. Sadler, Pres of International Markets (Age 50)
Who are Cigna's major shareholders?
Cigna's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Oregon Public Employees Retirement Fund (13.04%), BlackRock Inc. (11.04%), Massachusetts Financial Services Co. MA (2.83%), Northern Trust Corp (2.27%), Geode Capital Management LLC (2.03%) and Macquarie Group Ltd. (1.52%). Company insiders that own Cigna stock include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Eric P Palmer, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, John Partridge, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for Cigna.
Which institutional investors are selling Cigna stock?
CI stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Brandywine Global Investment Management LLC, Investec Asset Management LTD, Ruffer LLP, Orbimed Advisors LLC, Prudential PLC, Swedbank and Retirement Systems of Alabama. Company insiders that have sold Cigna company stock in the last year include Christopher J Hocevar, David Cordani, Hoeltzel Mary T Agoglia, Jason D Sadler, John Partridge, Michael W Triplett, Nicole S Jones and William D Zollars. View Insider Buying and Selling for Cigna.
Which institutional investors are buying Cigna stock?
CI stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Macquarie Group Ltd., Northern Trust Corp, Geode Capital Management LLC, Dimensional Fund Advisors LP, Massachusetts Financial Services Co. MA and Bank of New York Mellon Corp. View Insider Buying and Selling for Cigna.
How do I buy shares of Cigna?
Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cigna's stock price today?
One share of CI stock can currently be purchased for approximately $197.87.
How big of a company is Cigna?
Cigna has a market capitalization of $48.19 billion and generates $48.65 billion in revenue each year. The health services provider earns $2.64 billion in net income (profit) each year or $14.22 on an earnings per share basis. Cigna employs 46,000 workers across the globe.
What is Cigna's official website?
How can I contact Cigna?
Cigna's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]
MarketBeat Community Rating for Cigna (NYSE CI)
MarketBeat's community ratings are surveys of what our community members think about Cigna and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.
